Morgan Marks

Morgan Marks is a talented and highly motivated researcher serving as Senior Director at Merck and specializing in pharmacoepidemiology. With over three years of industry experience, they focus on the design and implementation of post-authorization safety studies in vaccines, alongside observational studies to support clinical development. Morgan has more than eight years of experience collaborating with academic and industry partners in research related to infectious diseases and cancer. They earned a PhD in Molecular Epidemiology from The Johns Hopkins Bloomberg School of Public Health and hold a BS in Microbiology from the University of Rochester.